Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Biorxiv : the Preprint Server for Biology
|
March 18, 2024
Rarγ -Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer
Dario De Felice, Alessandro Alaimo, Davide Bressan, et al.
EMBO Reports
|
March 7, 2022
Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence
Francesco Cambuli, Veronica Foletto, Alessandro Alaimo, et al.
Frontiers in Immunology
|
February 6, 2024
Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common <i>HLA-B</i> and <i>TAP</i> transcriptional silencing across advanced pediatric solid cancers
Wan Ching Lim, Maria Eugenia Marques Da Costa, Karine Godefroy, et al.
Science Translational Medicine
|
November 6, 2015
Plasma AR and abiraterone-resistant prostate cancer
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, et al.
Nature Communications
|
February 6, 2023
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice
Ramachandran Prakasam, Angela Bonadiman, Roberta Andreotti, et al.
Cancer Letters
|
March 8, 2022
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation
Marco Lorenzoni, Dario De Felice, Giulia Beccaceci, et al.
Nature Communications
|
April 26, 2020
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
Deli Liu, Jonathan E Shoag, Daniel Poliak, et al.
Cell Death & Disease
|
December 8, 2020
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors
Alessandro Alaimo, Marco Lorenzoni, Paolo Ambrosino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2018
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
Himisha Beltran, Clara Oromendia, Daniel C Danila, et al.
Cancer Cell
|
May 13, 2020
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer
Jian Carrot-Zhang, Nyasha Chambwe, Jeffrey S Damrauer, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Biorxiv : the Preprint Server for Biology
|
March 18, 2024
Rarγ -Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer
Dario De Felice, Alessandro Alaimo, Davide Bressan, et al.
EMBO Reports
|
March 7, 2022
Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence
Francesco Cambuli, Veronica Foletto, Alessandro Alaimo, et al.
Frontiers in Immunology
|
February 6, 2024
Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common <i>HLA-B</i> and <i>TAP</i> transcriptional silencing across advanced pediatric solid cancers
Wan Ching Lim, Maria Eugenia Marques Da Costa, Karine Godefroy, et al.
Science Translational Medicine
|
November 6, 2015
Plasma AR and abiraterone-resistant prostate cancer
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, et al.
Nature Communications
|
February 6, 2023
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice
Ramachandran Prakasam, Angela Bonadiman, Roberta Andreotti, et al.
Cancer Letters
|
March 8, 2022
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation
Marco Lorenzoni, Dario De Felice, Giulia Beccaceci, et al.
Nature Communications
|
April 26, 2020
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
Deli Liu, Jonathan E Shoag, Daniel Poliak, et al.
Cell Death & Disease
|
December 8, 2020
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors
Alessandro Alaimo, Marco Lorenzoni, Paolo Ambrosino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2018
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
Himisha Beltran, Clara Oromendia, Daniel C Danila, et al.
Cancer Cell
|
May 13, 2020
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer
Jian Carrot-Zhang, Nyasha Chambwe, Jeffrey S Damrauer, et al.
Page
of 7